The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects

European Respiratory Journal

Volumn 10, Issue 5, 1997, Pages 1008-1014

  Harbinson, P L ^a   MacLeod, D ^b   Hawksworth, R ^c   O'Toole, S ^b   Sullivan, P J ^a   Heath, P ^d   Kilfeather, S ^a   Page, C P ^a   Costello, J ^a   Holgate, S T ^b   Lee, T H ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UCB PHARMA   (Belgium)

Author keywords

asthma; CDP840; phosphodiesterase 4

Indexed keywords

4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0030984905     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10051008     Document Type: Article

References (47)

1. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806-81 7.
2. British Thoracic Society. Guidelines on the management of asthma: statement by the British Thoracic Society. Thorax 1993; 48 (Suppl. 2): S1-S24.
3. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild-to-moderately severe asthma in children. Pediatrics 1993; 92: 64-77.
4. MacLeod D, Djukanovic R. Low-dose theophylline: a new anti-inflammatory role in asthma management? Monaldi Arch Chest Dis 1996; 51: 30-34.
5. Crescioli S, Spinazzi A, Plebani M, et al. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy 1991; 66: 245-251.
6. Ward AJ, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline, an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147; 518-523.
7. Jaffar Z, Sullivan PJ, Page CP, Costello J. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur Respir J 1996; 9: 456-462.
8. Sullivan PJ, Bekir S, Jaffar Z, Page CP, Jeffrey P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-1008.
9. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
10. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMP. Science 1974; 184(132): 19-28.
11. Plaut M, Marone G, Gillespie E. The role of cyclic AMP in modulating cytotoxic T-lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents. J Immunol 1983; 131: 2945-2952.
12. Giembycz MA, Dent G. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 1992; 22: 337-344.
13. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46: 512-523.
14. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
15. Dent G, Giembycz MA, Evans PM, Rabe KF, Barnes PJ. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta-adrenoceptor agonist, albuterol. J Pharmacol Exp Ther 1994; 271: 1167-1174.
16. Hatzelmann A, Tenor H, Schudt C. Differential effects of nonselective and selective phosphodiesterase inhibitors on human eosinophil functions. Br J Pharmacol 1995; 114: 821-831.
17. Karlsson JA, Souness J, Webber S, Pollock K, Raeburn D. Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor, RP 73401. Int Arch Allergy Immunol 1995; 107: 425-426.
18. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990; 86: 801-808.
19. Cooper KD, Kang K, Chan SC, Hanifin JM. Phosphodiesterase inhibition by Ro20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro. J Invest Dermatol 1985; 84: 477-482.
20. Essayan DM, Huang SK, Undem BJ, Kagey Sobotka A, Lichtenstein LM. Modulation of antigen-and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J Immunol 1994; 153: 3408-3416.
21. Schade FU, Schudt C. The specific type III and IV phosphodiesterase inhibitor, zardaverine, suppresses formation of tumor necrosis factor by macrophages. Eur J Pharmacol 1993; 230: 9-14.
22. Peachell PT, Undem BJ, Schleimer RP, et al. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol 1992; 148: 2503-2510.
23. Banner KH, Page CP. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol 1995; 114: 93-98.
24. Underwood DC, Kotzer CJ, Bochnowicz S, et al. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea-pigs. J Pharmacol Exp Ther 1994; 270: 250-259.
25. Turner CR, Andresen CJ, Smith WB, Watson JW. Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med 1994; 149: 1153-1159.
26. Ortiz JL, Cortijo J, Valles JM, Bou J, Morcillo EJ. Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs. J Pharm Pharmacol 1993; 45: 1090-1092.
27. Fernandes LB, Ellis JL, Undem BJ. Potentiation of nonadrenergic noncholinergic relaxation of human isolated bronchus by selective inhibitors of phosphodiesterase isozymes. Am J Respir Crit Care Med 1994; 150: 1384-1390.
28. Cortijo J, Bou J, Beleta J, et al. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br J Pharmacol 1993; 108: 562-568.
29. Raeburn D, Underwood SL, Lewis SA, et al. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 1994; 113: 1423-1431.
30. Brunnee T, Engelstatter R, Steinijans VW, Kunkel G. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. Eur Respir J 1992; 5: 982-985.
31. Scott AI, Perini AF, Shering PA, Whalley LJ. In-patient major depression: is rolipram as effective as amitriptyline? Eur J Clin Pharmacol 1991; 40: 127-129.
32. Hughes B, Howat D, Lisle H, et al. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Br J Pharmacol 1996; 118: 1183-1191.
33. Gozzard N, El-Hashim A, Herd CM, et al. Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor, CDP840, on antigen-induced airway responses in neonatally-immunised rabbits. Br J Pharmacol 1996; 118: 1201-1208.
34. Chai H. Standardisation of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
35. Holgate ST. The mast cell and its function in allergic disease. Clin Exp Allergy 1991; 21 (Suppl. 3): 11-16.
36. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93: 1411-1421.
37. Gratziou C, Carroll M, Montefort S, Teran LM, Howarth PH, Holgate ST. Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am J Respir Crit Care Med 1996; 153: 515-520.
38. Metzger WJ, Zavala D, Richerson HB, et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am Rev Respir Dis 1987; 135: 433-440.
39. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79: 734-740.
40. Holgate ST, Breeding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996; 98: 1-13.
41. Pelikan Z, Pelikan Filipek M, Remeijer L. Effects of disodium cromoglycate and becloraethasone dipropionate on the asthmatic response to allergen challenge, II. Late asthmatic response (LAR). Ann Allergy 1988; 60: 217-225.
42. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-674.
43. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
44. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988; 1: 883-889.
45. Paggiaro PL, Dente FL, Vagaggini B, et al. Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. Respir Med 1991; 85: 401-406.
46. Kraan J, Koeter GH, Van Der Mark TW, et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 44-48.
47. Jenkins CR, Woolcock AJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax 1988; 43: 378-384.